Latest From Nutrinia
Multinational drug makers continue shuffling their senior management in Asia as Gilead Sciences has a new president for Japan, and so does Bristol-Myers Squibb. WuXi NextCode hires a new chief digital officer.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Having raised a precedent-setting $450m venture capital round in January 2015, Moderna is well on its way to a planned $600m additional fundraising. The privately held company is keeping quiet about what it's doing with all that cash. Tioma, Nutrina and Avelas are among other firms receiving VC financing.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced December 2014 through January 2015.
- Large Molecule
- Drug Delivery
- Therapeutic Areas
- Middle East
- Parent & Subsidiaries
- Senior Management
Michal Olshansky, CEO
Raanan Shamir, Medical Advisor
- Contact Info
6 Ha’khilazon St., 6th Fl.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.